Pros | 5Y returns in the top 25% of the category. 3Y returns in the top 25% of the category. Beats FD returns for both 3Y & 5Y duration. | Larger AUM within category. Beats FD returns for both 3Y & 5Y duration. | ||
Cons | - | - |
INDMoney rank | 2/8 | 6/8 | ||
Category | Equity, Sector - Healthcare | Equity, Sector - Healthcare | ||
Fund Age | 13 Years 3 Months | 13 Years 3 Months | ||
Fund AUM | ₹3989 Cr | ₹8265 Cr | ||
Min Investment |
|
| ||
Expense Ratio | 0.91% | 0.92% | ||
Exit Load | 0.5% | 1% | ||
Benchmark Index | BSE Healthcare TR INR | BSE Healthcare TR INR |
No of Holdings | 35 | 39 | ||
Top 5 Holdings |
|
| ||
No of Sectors | 3 | 1 | ||
Top 3 Sectors |
| Health (100%) | ||
Equity % | 96.6% | 97.37% | ||
Debt % | 0.07% | - | ||
P/E | 43.59 | 34.75 | ||
P/B | 5.89 | 5.37 | ||
Credit Quality | - | - | ||
Modified Duration | - | - | ||
YTM | - | - |
1-Month Return | -3.97% | -4.25% | ||
3-Month Return | -4.75% | -3.24% | ||
6-Month Return | -2.97% | -1.12% | ||
1-Year Return | -2.6% | 0.6% | ||
3-Year Return | 24.86% | 23.12% | ||
5-Year Return | 16.41% | 15% |
Sharpe | 1.13 | 0.97 | ||
Alpha | 2.62 | 0.33 | ||
Beta | 0.85 | 0.9 | ||
Standard Deviation | 14.42 | 15.32 | ||
Information Ratio | 0.17 | -0.32 |
Description | SBI Healthcare Opportunities Fund is an equity fund.The fund could potentially beat inflation in the long-run. | Nippon India Pharma Fund is an equity fund.The fund could potentially beat inflation in the long-run. | ||
Managers | Tanmaya Desai | Sailesh Raj Bhan, Lokesh Maru, Kinjal Desai, Divya Sharma |